JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Momose, M.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Momose, M.
Right arrow Articles by Schwaiger, M.
Journal of Nuclear Medicine Vol. 45 No. 3 471-477
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Evaluation of Cardiac ß-Adrenoreceptors in the Isolated Perfused Rat Heart Using (S)-11C-CGP12388

Mitsuru Momose, MD1, Sybille Reder, MT1, David M. Raffel, PhD2, Petra Watzlowik, PhD1, Hans-Jürgen Wester, PhD1, Ngoc Nguyen, MT1, Philip H. Elsinga, PhD3, Frank M. Bengel, MD1, Joerg Remien, MD4 and Markus Schwaiger, MD1

1 Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München, Munich, Germany
2 Department of Radiology, University of Michigan, Ann Arbor, Michigan
3 PET Center, Groningen University Hospital, Groningen, The Netherlands
4 Walther Straub für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany

(S)-11C-CGP12388 (11C-CGP12388) was recently developed as an in vivo PET tracer for the evaluation of cardiac ß-adrenergic receptors. The purpose of this study was to evaluate the myocardial kinetics of 11C-CGP12388 using the perfused rat heart model. Methods: Normal rat hearts were cannulated for retrograde perfusion according to the Langendorff method. Studies were performed using constant coronary flow rates of 12 mL/min (high flow: n = 6) and 6 mL/min (low flow: n = 6). ß-Adrenergic–blocking studies were also done using propranolol (blocking: n = 6). Two bolus injections of 11C-CGP12388 were administered at a 25-min interval, and time–activity curves were measured using bismuth germanate detectors. The ß-adrenergic receptor density (Bmax) and total distribution volume (DVtot) were estimated using compartmental modeling. After the experiment, Bmax in vitro was measured for all hearts using 3H-CGP12177, and the values were compared with the Bmax estimated in isolated hearts. Results: DVtot was significantly lower in the blocking group than in the high-flow group (P < 0.01), and there was no significant difference in DVtot between the high- and the low-flow groups. Bmax values estimated from 11C-CGP12388 kinetics were 5.05 ± 0.90 pmol/g under the high-flow model and 5.20 ± 0.63 pmol/g under the low-flow model. The Bmax results in isolated hearts correlated significantly with the measured in vitro Bmax values (r2 = 0.69; P < 0.001). Conclusion: ß-Adrenoreceptor density in the isolated rat heart can be quantified using 11C-CGP12388 and a 2-injection protocol. The binding of the tracer was flow independent, with low nonspecific binding. These results suggest that 11C-CGP12388 is a promising PET tracer that may be applicable to human studies.

Key Words: 11C-CGP12388 • ß-adrenoreceptor density • isolated rat heart • Langendorff • PET







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.